More from Health and Lifestyle

classified as:
  • News releases
  • press_releases mcgill.ca/newsroom
  • Health and Lifestyle
  • External
subscribe

Mindfulness training shows promise for maintaining weight loss

Can mindfulness training help overweight people shed pounds and keep them off?  McGill University researchers surveyed the growing body of studies investigating that question, and came away encouraged.

...
Published: 23 Nov 2017

Meeting a microbe in the morning or in the evening: is it all the same?

Does the time of day matter when our body is infected by a parasite? According to new research from McGill University, it matters a great deal.

...
Published: 8 Sep 2017

MUHC study calls for action to help adolescents with diabetes transition to adult care

Adolescence can be a turbulent period of life, with struggles to establish autonomy, identity issues and risk-taking behaviours. For young adults with a chronic illness such as type 1 diabetes, this transition phase also brings about other challenges as they assume an increased responsibility for their overall health....

Published: 17 Aug 2017

Newly discovered pathway for pain processing could lead to new treatments

The discovery of a new biological pathway involved in pain processing offers hope of using existing cancer drugs to replace the use of opioids in chronic pain treatment, according to scientists at McGill University.

...
Published: 8 Aug 2017

UAlberta and McGill scientists uncover a hidden calcium cholesterol connection

By Ross Neitz, University of Alberta

It’s well known that calcium is essential for strong bones and teeth, but new research shows it also plays a key role in moderating another important aspect of health—cholesterol.

Scientists at the University of Alberta and McGill University have discovered a direct link between calcium and cholesterol, a discovery that could pave the way for new ways of treating high blood cholesterol. 

...
Published: 26 Jul 2017

Diabetes drug may help symptoms of autism-associated condition

Metformin, the most widely used drug to treat type 2 diabetes, could potentially be used to treat symptoms of Fragile X syndrome, an inherited form of intellectual disability and a cause of some forms of autism.

A new study led by researchers at McGill University, the University of Edinburgh and Université de Montréal has found that metformin improves social, behavioural and morphological defects in Fragile X mice.

...
Published: 15 May 2017

Solving medical “cold cases” through genetics

Researchers have identified the genetic mutation responsible for one patient's serious health problems, finally solving a medical mystery that has endured for over 30 years....

Published: 6 Apr 2017

Encouraging results for patients with aggressive brain cancer

Being diagnosed with a malignant brain tumor is devastating news for patients and their loved ones. Whereas some types of tumor respond well to treatment, others such as glioblastomas – the most common and aggressive brain tumors – are known to recur and progress within short times from the diagnosis. Patients diagnosed with this type of cancer, and who undergo current standard treatment, have a median survival of 16 months.

...
Published: 23 Mar 2017

Woodstoves are good for the soul, bad for the heart

The risk of acute myocardial infarction for the elderly living in and around small cities is increased by air pollution caused by biomass burning from woodstoves.  

It is well documented that air pollution in big cities causes heart and lung problems. But what are its consequences on people in smaller urban centres?

...
Published: 27 Feb 2017

A prescription with legs

...

Published: 23 Feb 2017

Targeting the biological clock could slow the progression of cancer

Does the biological clock in cancer cells influence tumour growth? Yes, according to a study conducted by Nicolas Cermakian, a professor in McGill University’s Department of Psychiatry.

Published in the journal BMC Biology, these results show for the first time that directly targeting the biological clock in a cancerous tumour has an impact on its development.

...
Published: 16 Feb 2017

Breakthrough in MS treatment

In separate clinical trials, a drug called ocrelizumab has been shown to reduce new attacks in patients with relapsing remitting multiple sclerosis (MS), and new symptom progression in primary progressive MS.

...
Published: 9 Jan 2017

Pages